MaxPotent Pharma Summit 2025

MaxPotent Pharma Summit 2025 is the leading industry event dedicated to the evolving challenges and advances in the field of high-potency active pharmaceutical ingredients (HPAPIs). As the global HPAPI market is expected to reach $46.9 billion by 2030, driven by increasing demand for oncology drugs, antibody drug conjugates (ADCs), and precision medicine, this summit is a key platform for pharmaceutical innovators, regulatory experts, and contract manufacturing organizations (CMOs/CDMOs).
Over the course of two highly specialized days, we will delve into the latest regulatory frameworks, containment technologies, process design innovations, and risk mitigation strategies, ensuring that industry stakeholders can navigate compliance, optimize manufacturing, and improve occupational safety in high-potency drug development.